Literature DB >> 6139632

Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis.

M A Karmali, M Petric, C Lim, P C Fleming, B T Steele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6139632     DOI： 10.1016/s0140-6736(83)91167-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  69 in total

1.  Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome.

Authors:  Philipp A Lang; Ortraud Beringer; Jan P Nicolay; Oliver Amon; Daniela S Kempe; Tobias Hermle; Philipp Attanasio; Ahmad Akel; Richard Schäfer; Björn Friedrich; Teut Risler; Matthias Baur; Christoph J Olbricht; Lothar Bernd Zimmerhackl; Peter F Zipfel; Thomas Wieder; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-04-19       Impact factor: 4.599

2.  Weather and hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Fabio Paglialonga; Sara Testa; Silvana Loi; Alberto Edefonti; Daniele Cusi; Fabio Sereni
Journal:  Pediatr Nephrol       Date:  2003-09-05       Impact factor: 3.714

3.  Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24.

Authors:  Melissa M Kendall; Charley C Gruber; David A Rasko; David T Hughes; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

4.  EutR is a direct regulator of genes that contribute to metabolism and virulence in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Deborah H Luzader; David E Clark; Laura A Gonyar; Melissa M Kendall
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

5.  Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.

Authors:  Naoko Morinaga; Kinnosuke Yahiro; Gen Matsuura; Masaharu Watanabe; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 6.  Novel approaches to bacterial infection therapy by interfering with bacteria-to-bacteria signaling.

Authors:  Vanessa Sperandio
Journal:  Expert Rev Anti Infect Ther       Date:  2007-04       Impact factor: 5.091

Review 7.  Inter-kingdom signalling: communication between bacteria and their hosts.

Authors:  David T Hughes; Vanessa Sperandio
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

8.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

9.  Novel repressor of Escherichia coli O157:H7 motility encoded in the putative fimbrial cluster OI-1.

Authors:  Sarah E Allison; Uma Silphaduang; Mariola Mascarenhas; Paulina Konczy; Quyen Quan; Mohamed Karmali; Brian K Coombes
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

10.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.